Article Information
History
- September 23, 2020.
Article Versions
- You are currently viewing Version 1 of this article (September 23, 2020 - 08:54).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Matthias M. Schneider1,#,
- Marc Emmenegger2,#,
- Catherine K. Xu1,#,
- Itzel Condado Morales2,#,
- Priscilla Turelli3,
- Manuela R. Zimmermann1,
- Beat M. Frey4,
- Sebastian Fiedler5,
- Viola Denninger5,
- Georg Meisl1,
- Vasilis Kosmoliaptsis6,7,
- Heike Fiegler5,
- Didier Trono3,
- Tuomas P. J. Knowles1,8,* and
- Adriano Aguzzi2,*
- 1Centre for Misfolding Diseases, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom
- 2Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland
- 3School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
- 4Regional Blood Transfusion Service Zurich, Swiss Red Cross, 8952 Schlieren, Switzerland
- 5Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Rd, Cambridge CB1 8DH, UK
- 6Department of Surgery, Addenbrooke’s Hospital, University of Cambridge, Hills Road, Cambridge CB2 0QQ, United Kingdom
- 7NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation, University of Cambridge, Hills Road, Cambridge CB2 0QQ, United Kingdom
- 8Cavendish Laboratory, Department of Physics, University of Cambridge, JJ Thomson Ave, Cambridge CB3 0HE, United Kingdom
- ↵*to whom correspondence should be addressed: adriano.aguzzi{at}usz.ch or tpjk2{at}cam.ac.uk
↵# equal contribution
Posted September 23, 2020.
Microfluidic Affinity Profiling reveals a Broad Range of Target Affinities for Anti-SARS-CoV-2 Antibodies in Plasma of Covid Survivors
